Rash Management : Episode 6

Video

Interdisciplinary Approach to Managing Skin Toxicities

Kathryn Ciccolini, RN, BSN, OCN, an oncology nurse at Memorial Sloan-Kettering Cancer Center (MSKCC), discusses the importance of an interdisciplinary team in the management of skin toxicities associated with anticancer therapies.

At MSKCC, there is a team dedicated to the management of skin toxicities associated with anticancer agents. This clinical and administrative team consists of a physician, two registered nurses, a patient care technician who is a trained medical photographer, and an excellent administrative team.

The success of this team is derived from being proactive with the management of dermatologic adverse events, Ciccolini says. The goal of the interdisciplinary team is to ensure that anticancer therapy does not need to be stopped, as a result dermatologic side effect.

In order for an interdisciplinary team to be successful, healthy, and high performing, it must continuously care about efficiency, productivity, trust, cohesion, and effective communication, believes Ciccolini. Moreover, the team should constantly strategize on ways to build, change, and improve for the future. Every member of the team is a critical piece toward patient care, adds Ciccolini.

Related Videos
Alec Watson, MD
Ashkan Emadi, MD, PhD
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss factors that influence later-line treatment choices in chronic myeloid leukemia.
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, on the implications of the FDA approval of asciminib in newly diagnosed CP-CML.
Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
Balazs Halmos, MD
Balazs Halmos, MD
Eunice S. Wang, MD
Nosha Farhadfar, MD, and Chandler Park, MD, FACP
Marcella Ali Kaddoura, MD